Patents Examined by Jehannie S Sitton
  • IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapy
    Patent number: 11028441
    Abstract: The present invention concerns the use of IL-10 as a biological marker for predicting the responsiveness of a house dust mite allergic patient to house dust mite allergen immunotherapy.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: June 8, 2021
    Assignee: STALLERGENES
    Inventors: Laurent Mascarell, Véronique Bodo, Philippe Moingeon, Vincent Lombardi, Claire Gueguen